Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking

Biochemical and Biophysical Research Communications

Volumn 434, Issue 1, 2013, Pages 155-161

  Funasaka, Tatsuyoshi ^a   Balan, Vitaly ^b   Raz, Avraham ^b   Wong, Richard W ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer progression; Galectin 3; Nuclear pore complex; Nuclear transport; Nucleoporin

Indexed keywords

BETA CATENIN; CYCLIN D1; GALECTIN 3; MESSENGER RNA; NUCLEOPORIN 98; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FRA 1;

ARTICLE; CELL GROWTH; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; BETA CATENIN; CELL PROLIFERATION; DISEASE PROGRESSION; GALECTIN 3; HELA CELLS; HUMANS; MCF-7 CELLS; NEOPLASMS; NUCLEAR PORE COMPLEX PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84876785822     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.052     Document Type: Article

References (22)

1. Xu S., Powers M.A. Nuclear pore proteins and cancer. Semin. Cell Dev. Biol. 2009, 20:620-630.
2. Funasaka T., Wong R.W. The role of nuclear pore complex in tumor microenvironment and metastasis. Cancer Metas. Rev. 2011, 30:239-251.
3. Tran E.J., Wente S.R. Dynamic nuclear pore complexes: life on the edge. Cell 2006, 125:1041-1053.
4. Martinez N., Alonso A., Moragues M.D., Ponton J., Schneider J. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res. 1999, 59:5408-5411.
5. Kao J., Salari K., Bocanegra M., Choi Y.L., Girard L., Gandhi J., Kwei K.A., Hernandez-Boussard T., Wang P., Gazdar A.F., Minna J.D., Pollack J.R. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 2009, 4:e6146.
6. Gough S.M., Slape C.I., Aplan P.D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011, 118:6247-6257.
7. Soman N.R., Correa P., Ruiz B.A., Wogan G.N. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc. Natl. Acad. Sci. USA 1991, 88:4892-4896.
8. Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5:29-41.
9. Takenaka Y., Fukumori T., Raz A. Galectin-3 and metastasis. Glycoconj. J. 2004, 19:543-549.
10. Nakahara S., Hogan V., Inohara H., Raz A. Importin-mediated nuclear translocation of galectin-3. J. Biol. Chem. 2006, 281:39649-39659.
11. Califice S., Castronovo V., Bracke M., van den Brûle F. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 2004, 23:7527-7536.
12. Ellerhorst J.A., Stephens L.C., Nguyen T., Xu X.C. Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP. Prostate 2002, 50:64-70.
13. Honjo Y., Inohara H., Akahani S., Yoshii T., Takenaka Y., Yoshida J., Hattori K., Tomiyama Y., Raz A., Kubo T. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin. Cancer Res. 2000, 6:4635-4640.
14. Takenaka Y., Fukumori T., Yoshii T., Oka N., Inohara H., Kim H.R., Bresalier R.S., Raz A. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol. Cell. Biol. 2004, 24:4395-4406.
15. Bonifaci N., Moroianu J., Radu A., Blobel G. Karyopherin ß2 mediates nuclear import of a mRNA binding protein. Proc. Natl. Acad. Sci. USA 1997, 94:5055-5060.
16. Funasaka T., Nakano H., Wu Y., Hashizume C., Gu L., Nakamura T., Wang W., Zhou P., Moore M.A., Sato H., Wong R.W. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis. Cell Cycle 2011, 10:1456-1467.
17. Nakano H., Funasaka T., Hashizume C., Wong R.W. Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. J. Biol. Chem. 2010, 285:10841-10849.
18. Tsay Y.G., Lin N.Y., Voss P.G., Patterson R.J., Wang J.L. Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts. Exp. Cell Res. 1999, 252:250-261.
19. Shimura T., Takenaka Y., Tsutsumi S., Hogan V., Kikuchi A., Raz A. Galectin-3, a novel binding partner of ß-catenin. Cancer Res. 2004, 64:6363-6367.
20. Cowles E.A., Agrwal N., Anderson R.L., Wang J.L. Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J. Biol. Chem. 1990, 265:17706-17712.
21. Mazurek N., Sun Y.J., Price J.E., Ramdas L., Schober W., Nangia-Makker P., Byrd J.C., Raz A., Bresalier R.S. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Res. 2005, 65:10767-10775.
22. Funasaka T., Tsuka E., Wong R.W. Regulation of autophagy by nucleoporin Tpr. Sci. Rep. 2012, 2:878. 10.1038/srep00878.